Projects per year
Personal profile
Biography
I am Pharmacologist interested in psychoactive drugs, particularly cannabinoids, opioids and psychedelics. My lab studies how these molecules interact with G protein coupled receptors and ion channels to exert their effects. Currently my work is focussed on the pharmacology and toxicity of emerging synthetic cannabinoid receptor agonists (Spice/K2), the molecular mechanisms underlying the potential therapeutic actions of phytocannabinoids, the pharmacology of novel psychedelics and the interactions of clinically used opioids naturally occuring variants of opioid receptors.
Education/Academic qualification
Pharmacology, PhD, Identification of endogenous ligands for the haloperidol-sensitive sigma receptor in rat brain, University of Washington (UW)
Award Date: 18 Dec 1992
Pharmacology, Genetics, BSc (Hons), An investigation of the neurotoxicity of textilotoxin and its subunits, University of Sydney
Award Date: 25 May 1988
Fingerprint
Dive into the research topics where Mark Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
FAAB: ARC Training Centre for Facilitated Advancement of Australia's Bioactives (FAAB)
Rodger, A. (Primary Chief Investigator), Sunna, A. (Chief Investigator), Garcia-Bennett, A. (Chief Investigator), Guillemin, G. (Chief Investigator), Packer, N. (Chief Investigator), Thaysen-Andersen, M. (Chief Investigator), Cain, A. (Chief Investigator), Connor, M. (Chief Investigator), Haynes, P. (Chief Investigator), Paulsen, I. (Chief Investigator), Ponton, F. (Chief Investigator), Tetu, S. (Chief Investigator), Wang, Y. (Chief Investigator), Adcock, J. (Chief Investigator), Callahan, D. (Chief Investigator), Walsh, T. R. (Chief Investigator), Joyce, P. (Chief Investigator), Prestidge, C. A. (Chief Investigator), Reddy, N. (Chief Investigator), Ashton, J. (Partner Investigator), Ball, M. (Partner Investigator), Bucca, D. (Partner Investigator), de Silva, T. (Partner Investigator), Ferguson, K. (Partner Investigator), Gilbert, A. (Partner Investigator), Gilbert, E. (Partner Investigator), Hayes, E. (Partner Investigator), Mazumder, D. (Partner Investigator), Morrison, J. (Partner Investigator), Petrie, J. (Partner Investigator), Pollard, N. (Partner Investigator), Ruff, N. (Partner Investigator), Stockham, K. (Partner Investigator), Winberg, P. (Partner Investigator) & De Simone, A. (Partner Investigator)
21/02/22 → 20/02/27
Project: Research
-
Therapeutic drug actions in the nervous system
Connor, M. (Primary Chief Investigator)
13/12/20 → 31/12/25
Project: Research
-
Development of next-generation targeted therapies for epilepsy and pain based on cannabinoid derivatives
Bladen, C. (Primary Chief Investigator) & Connor, M. (Sponsor)
3/07/17 → …
Project: Research
-
Advanced protein quantification capability
Walker, A. K. (Primary Chief Investigator), Lee, A. (Chief Investigator), Connor, M. (Chief Investigator), Atkin, J. (Chief Investigator), Lim, E. (Chief Investigator), Baker, M. S. (Chief Investigator), Rizos, H. (Chief Investigator), Phillips, J. K. (Chief Investigator), Yang, S. (Chief Investigator) & Blair, I. (Chief Investigator)
1/01/17 → …
Project: Research
-
The pharmacology and toxicity of synthetic cannabinoids
Connor, M. (Primary Chief Investigator), Kassiou, M. (Chief Investigator) & McGregor, I. (Chief Investigator)
1/01/16 → …
Project: Research
-
Activation of CB2 receptors by (−)-Cannabichromene but not (+)-Cannabichromene
Udoh, M., Santiago, M., Haneef, S., Rodger, A., Marlowe, C. K., Barr, P. J. & Connor, M., 1 Feb 2025, In: Cannabis and Cannabinoid Research. 10, 1, p. e94-e101 8 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Clinical significance of GPR68 expression in cutaneous melanoma
Isherwood, S., O'Sullivan, F., Preda, V., Connor, M., Petocz, P. & Rizos, H., 2025. 1 p.Research output: Contribution to conference › Poster › peer-review
-
Polyunsaturated fatty acids and their endocannabinoid-related metabolites activity at human TRPV1 and TRPA1 ion channels expressed in HEK-293 cells
Abate, A., Santiago, M., Garcia-Bennett, A. & Connor, M., 2025, In: PeerJ. 13, 3, p. 1-20 20 p., e19125.Research output: Contribution to journal › Article › peer-review
Open AccessFile24 Downloads (Pure) -
Uncovering the antifungal potential of Cannabidiol and Cannabidivarin
Dinh, H., Fernandes, K. E., Erpf, P. E., Clay, E. J. M., Tay, A. P., Nagy, S. S., Schaefer, S., Maharjan, R., Lenardon, M. D., Multari, D. H., Haynes, P. A., Paulsen, I. T., Santiago, M. J., Connor, M., Carter, D. & Cain, A. K., 2025, In: PLoS Neglected Tropical Diseases. 19, 6, p. 1-24 24 p., e0013081.Research output: Contribution to journal › Article › peer-review
Open AccessFile33 Downloads (Pure) -
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: molecular pharmacology and disease associations
Foyzun, T., Whiting, M., Velasco, K. K., Jacobsen, J. C., Connor, M. & Grimsey, N. L., Aug 2024, In: British Journal of Pharmacology. 181, 15, p. 2391-2412 22 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile3 Citations (Scopus)39 Downloads (Pure)
Datasets
-
AtT-20 cell line expression data
Junqueira Santiago, M. (Contributor) & Connor, M. (Owner), Macquarie University, 10 Nov 2022
DOI: 10.25949/21529404.v1
Dataset